Your browser doesn't support javascript.
loading
Antibodies, epicenter of SARS-CoV-2 immunology.
Pecetta, Simone; Pizza, Mariagrazia; Sala, Claudia; Andreano, Emanuele; Pileri, Piero; Troisi, Marco; Pantano, Elisa; Manganaro, Noemi; Rappuoli, Rino.
Afiliação
  • Pecetta S; Research and Development Centre, GlaxoSmithKline (GSK), Siena, Italy.
  • Pizza M; Research and Development Centre, GlaxoSmithKline (GSK), Siena, Italy.
  • Sala C; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Andreano E; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Pileri P; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Troisi M; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Pantano E; University of Siena, Department of Biotechnology, Chemistry and Pharmacy, Siena, Italy.
  • Manganaro N; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
  • Rappuoli R; Monoclonal Antibody Discovery (MAD) Lab, Fondazione Toscana Life Sciences, Siena, Italy.
Cell Death Differ ; 28(2): 821-824, 2021 02.
Article em En | MEDLINE | ID: mdl-33500559
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / SARS-CoV-2 / COVID-19 / Anticorpos Antivirais Idioma: En Ano de publicação: 2021 Tipo de documento: Article